Pfizer Investors Ask 3rd Circ. To Revive Alzheimer's Drug Row
A class of Pfizer Inc. shareholders asked the Third Circuit on Wednesday to revive a securities fraud suit, arguing that a press release updating the public with the status of an...To view the full article, register now.
Already a subscriber? Click here to view full article